IL-32γ Inhibits Acetaminophen-Induced Acute Hepatotoxicity through Inactivation of NF-κB and Stat1 Signals

Although several studies have shown physiological functions of interleukin (IL)-32, the role of IL-32 in liver has not yet been reported. This study was initiated to examine the effects of IL-32γ on APAP-induced acute hepatic failure in IL-32γ transgenic mice. IL-32Γ overexpressing and non-transgenic mice received 500 mg/kg Acetoaminophen (APAP) intraperitoneally. Serum alanine transaminase and aspartate transaminase were significantly lower in the APAP treated IL-32γ overexpressing mice compared with those APAP-treated non-transgenic. IL-32γ markedly reduced a restricted area of the necrosis and inflammation. APAP-induced reduced glutathione depletion, induction of nitric oxide and lipid peroxidation, and cytochrome P4502E1 expression was significantly lowered in the IL-32γ overexpressing mice. Elevation of Kupffer cells and natural killer cells by APAP were reduced in the IL-32γ overexpressing mice. The expression of IL-1α, IL-1rα, macrophage inflammatory protein-2, C-C motif chemokine ligand 5 and tissue inhibitor of metalloproteinase-1 was increased by APAP in non-transgenic mice, and were lowered in the IL-32γ overexpressing mice. Moreover, APAP-induced nuclear transcription factor-kappa B (NF-κB) and signal transducers and activators of transcription 1 (STAT1) activities were greatly lowered in the IL-32γ overexpressing mice. The results indicate that IL-32γ could effectively inhibit drug-induced hepatic failure, and reduce the number of cytotoxic immune cells and pro-inflammatory cytokine production through reduced activities of NF-κB and STAT1. This might be attributable to lowering APAP-induced liver toxicity in IL-32γ overexpressing mice.

[1]  B. Gao,et al.  STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. , 2012, Journal of hepatology.

[2]  Lu-nan Yan,et al.  Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. , 2012, World journal of gastroenterology.

[3]  A. Fouad,et al.  Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity. , 2012, Environmental toxicology and pharmacology.

[4]  Hartmut Jaeschke,et al.  Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[5]  D. Yoon,et al.  Interleukin‐32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3 , 2012, Immunology.

[6]  B. M. Forman,et al.  The G‐Protein‐coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light‐chain enhancer of activated B cells (NF‐κB) in mice , 2011, Hepatology.

[7]  U. Boelsterli,et al.  Acetaminophen overdose‐induced liver injury in mice is mediated by peroxynitrite independently of the cyclophilin D‐regulated permeability transition , 2011, Hepatology.

[8]  L. MacMillan-Crow,et al.  Acetaminophen-Induced Hepatotoxicity in Mice Occurs with Inhibition of Activity and Nitration of Mitochondrial Manganese Superoxide Dismutase , 2011, Journal of Pharmacology and Experimental Therapeutics.

[9]  H. J. Kim,et al.  IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals , 2011, Oncogene.

[10]  L. Joosten,et al.  Inflammation-dependent secretion and splicing of IL-32γ in rheumatoid arthritis , 2011, Proceedings of the National Academy of Sciences.

[11]  C. Trautwein,et al.  Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. , 2010, The Journal of clinical investigation.

[12]  T. Billiar,et al.  Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine production. , 2010, Journal of hepatology.

[13]  Luke Barron,et al.  Macrophages: Master Regulators of Inflammation and Fibrosis , 2010, Seminars in liver disease.

[14]  I. Čavar,et al.  The role of prostaglandin E2 in acute acetaminophen hepatotoxicity in mice. , 2010, Histology and histopathology.

[15]  Hua Huang,et al.  IL-32 Is a Host Protective Cytokine against Mycobacterium tuberculosis in Differentiated THP-1 Human Macrophages , 2010, The Journal of Immunology.

[16]  D. Yoon,et al.  A proinflammatory cytokine interleukin‐32β promotes the production of an anti‐inflammatory cytokine interleukin‐10 , 2009, Immunology.

[17]  E. Edelman,et al.  NF-κB Activity in Endothelial Cells is Modulated by Cell Substratum Interactions and Influences Chemokine-Mediated Adhesion of Natural Killer Cells , 2009, Cell transplantation.

[18]  I. Goshen,et al.  Interleukin-1 (IL-1): A central regulator of stress responses , 2009, Frontiers in Neuroendocrinology.

[19]  D. Preciado,et al.  The Role of Inflammatory Mediators in the Pathogenesis of Otitis Media and Sequelae , 2008, Clinical and experimental otorhinolaryngology.

[20]  D. Yoon,et al.  Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA. , 2008, Journal of immunological methods.

[21]  A. Takayanagi,et al.  Epithelial overexpression of interleukin‐32α in inflammatory bowel disease , 2007 .

[22]  C. Dinarello,et al.  IL-32, a novel cytokine with a possible role in disease , 2006, Annals of the rheumatic diseases.

[23]  F. Gonzalez,et al.  Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. , 2005, Mutation research.

[24]  N. Kaplowitz,et al.  Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. , 2004, Gastroenterology.

[25]  Won Ho Kim,et al.  IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[26]  Z. Tian,et al.  Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. , 2002, The Journal of clinical investigation.

[27]  Ann Richmond,et al.  NF-κB, chemokine gene transcription and tumour growth , 2002, Nature Reviews Immunology.

[28]  M. Yoneda,et al.  Macrophage inflammatory protein-2 induced by TNF-α plays a pivotal role in concanavalin A-induced liver injury in mice , 2001 .

[29]  Huiling He,et al.  Identification of a novel gene expressed in activated natural killer cells and T cells. , 1992, Journal of immunology.

[30]  D. Prough,et al.  Monitoring hepatic function. , 1988, Critical care clinics.

[31]  L. James,et al.  Mechanisms of acetaminophen-induced liver necrosis. , 2010, Handbook of experimental pharmacology.

[32]  Tsutomu Shimada,et al.  Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. , 2006, Drug metabolism and pharmacokinetics.

[33]  D. Yoon,et al.  Interleukin-32A Cytokine and Inducer of TNFα , 2005 .

[34]  Laura P James,et al.  Acetaminophen-induced hepatotoxicity. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[35]  M. Yoneda,et al.  Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice. , 2001, Journal of hepatology.

[36]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.